| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.1 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |